TrialThe Journal of infectious diseases2018

Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants From Asian Countries.

S M Garland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.